论文部分内容阅读
目前认为流行性出血热(下称出血热)发病机理与免疫有关,由免疫反应导致微循环障碍。我院于1982年起试用山莨菪碱治疗出血热110例,取得初步疗效。现报告如下。
The current epidemic of hemorrhagic fever (hereinafter referred to as hemorrhagic fever) pathogenesis and immune-related, caused by the immune response to microcirculation. Our hospital in 1982 trial of anisodamine in the treatment of hemorrhagic fever in 110 cases, achieved initial effect. The report is as follows.